1.
Haematologica
; 107(7): 1731-1735, 2022 07 01.
Article
in English
| MEDLINE | ID: covidwho-1745156
2.
Int J Infect Dis
; 104: 379-381, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1385707
ABSTRACT
Microbiological response of SARS-CoV-2 to remdesivir in immunocompromised patients has not been evaluated. We present the case of a severely immunocompromised patient with persistent replication of SARS-CoV-2, who required different courses of remdesivir. Short courses of remdesivir might be insufficient in immunocompromised patients due to prolonged viral clearance.